Sanofi SA (SAN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

€72.72

Buy

€72.74

arrow-down€-7.19 (-9.00%)

Prices updated at 30 Jul 2026, 14:59 CEST

Prices minimum 15 mins delay

Prices in EUR

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this im ...

FTSE EuroFirst 300

0.92%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Annual general meeting	Apr 2027
Annual report	Feb 2027
Final results	Jan 2027
Half yearly results	Jul 2026

	Previous date
Annual general meeting	Apr 2026
Annual report	Feb 2026
Final results	Jan 2026
Half yearly results	Jul 2025

Company reports

31 Dec 2025

Annual Report

30 Jun 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.